New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareCartalax vs Matrixyl

Cartalax vs Matrixyl

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Cartalax
Skin & Cosmetic
Matrixyl
Summary
Cartalax is a tetrapeptide bioregulator (Ala-Glu-Asp-Pro) developed by Professor Vladimir Khavinson for cartilage and connective tissue. It is tissue-specific for chondrocytes and cartilaginous structures, supporting cartilage matrix synthesis, slowing degenerative changes, and promoting joint longevity. It is used in the context of osteoarthritis, joint aging, and athletic cartilage preservation.
Matrixyl is the most widely used collagen-stimulating cosmetic peptide. As a matrikine — a fragment of type I procollagen — it signals skin cells to synthesize new collagen, elastin, and fibronectin, reducing wrinkle depth and improving skin firmness and elasticity.
Half-Life
Short (minutes); gene-regulatory effects are sustained
N/A — topical; sustained signaling effects on fibroblasts persist beyond single application
Admin Route
SubQ, Oral
Topical
Research
Typical Dose
10 mg per day
3–8% concentration
Frequency
Daily for 10–30 days
Once or twice daily
Key Benefits
  • Supports cartilage matrix synthesis and maintenance
  • May slow progression of osteoarthritic cartilage degradation
  • Reduces chondrocyte apoptosis
  • Promotes joint longevity in aging and high-impact sports
  • Anti-aging effects on connective tissue
  • Complementary to BPC-157 and TB-500 in joint recovery protocols
  • Well tolerated in available human and animal research
  • Stimulates collagen I, III, and IV synthesis
  • Increases fibronectin and glycosaminoglycan production
  • Reduces wrinkle depth and length by 27–68% (studies)
  • Improves skin firmness and elasticity
  • Reduces dark circles and undereye bags
  • Synergistic with retinol, vitamin C, and growth factors
  • Suitable for all skin types including sensitive
  • Well-studied with published clinical data
Side Effects
  • Generally well tolerated
  • Mild injection site reactions
  • No significant adverse events reported at standard doses
  • Exceptional safety profile
  • Non-irritating, suitable for sensitive skin
  • No known adverse effects at cosmetic concentrations
Stacks With